DEUTSCHE BANK AG\ - RENEO PHARMACEUTICALS INC ownership

RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 42 filers reported holding RENEO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of RENEO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$14,000
-68.9%
4,722
-10.6%
0.00%
Q4 2021$45,000
+66.7%
5,282
+45.7%
0.00%
Q3 2021$27,000
-22.9%
3,626
-3.2%
0.00%
Q2 2021$35,0003,7450.00%
Other shareholders
RENEO PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
RiverVest Venture Management LLC 2,409,220$8,071,0009.37%
Abingworth LLP 2,073,957$6,948,0002.38%
Aisling Capital Management LP 886,075$2,968,0001.97%
NEA Management Company, LLC 4,786,921$16,036,0000.80%
Novo Holdings A/S 3,430,377$11,492,0000.55%
Ikarian Capital, LLC 155,819$521,0000.10%
Rock Springs Capital Management LP 1,143,185$3,830,0000.10%
Ergoteles LLC 37,640$126,0000.00%
MAI Capital Management 63,210$212,0000.00%
RBF Capital, LLC 14,536$49,0000.00%
View complete list of RENEO PHARMACEUTICALS INC shareholders